Andrey Rudakov | Bloomberg | Getty Images
The pharmaceutical giant Pfizer has struck a deal with therapeutic game developer Akili Interactive Labs to test whether Project:EVO, which runs on iPhones and iPads, can discern cognitive differences in healthy older adults at risk of developing Alzheimer's disease. The agreement will be announced Thursday morning.
Read the entire story here.
—By James Temple, recode.net.
CNBC's parent NBC Universal is an investor in re/code's parent Revere Digital, and the companies have a content-sharing arrangement.